FB102-701: Severe to Very Severe Alopecia Areata

CONDITION

Skin

GENDER

All

AGE GROUP

From 18

to 75 years

STATUS

Not yet recruiting

FB102-701: A Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Safety and Efficacy of FB102 in Patients with Severe to Very Severe Alopecia Areata

CONTACT DETAILS

Clinical Trial Site: East Sydney Doctors
Phone Number: 02 9332 2531 Email: trials@eastsydneydoctors.com.au Location: 102 Burton Street, Darlinghurst NSW, Australia

Studies Contact Form

  • This field is hidden when viewing the form

Approved By: Bellberry              

Clinical Trial Registry Link: